Literature DB >> 25536611

The influence of methylenetetrahydrofolate reductase and thymidylate synthetase gene polymorphisms on lung adenocarcinoma occurrence.

Milena Cavic1, Ana Krivokuca, Jelena Spasic, Ksenija Brotto, Emina Malisic, Davorin Radosavljevic, Sinisa Radulovic, Radmila Jankovic.   

Abstract

PURPOSE: Methylenetetrahydrofolate reductase (MTHFR) and thymidylate synthetase (TYMS) are suggested as risk factors for lung cancer. The purpose of this study was to analyze the association of MTHFR C677T polymorphism and variable number tandem repeat 2R/3R and single nucleotide polymorphism G>C in the 3R allele of the TYMS gene with lung adenocarcinoma.
METHODS: A case-control study including lung adenocarcinoma patients and healthy subjects was performed. Restriction fragment length polymorphism analysis was used for genotyping. Descriptive analyses included genotype and allelic frequencies; the odds ratio and 95% confidence interval were calculated as an estimate of relative risk. Significance was set at p<0.05.
RESULTS: A significant difference in CC vs TT+CT MTHFR genotype distribution was observed between patients and controls. There was no significant association between the TYMS polymorphisms and the risk of lung adenocarcinoma.
CONCLUSIONS: The MTHFR 677T allele is likely to have a protective effect against lung adenocarcinoma development.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25536611

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  5 in total

1.  Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer.

Authors:  Jelena Spasic; Milena Cavic; Nemanja Stanic; Bojan Zaric; Tomi Kovacevic; Davorin Radosavljevic; Ljudmila Nagorni-Obradovic
Journal:  Dose Response       Date:  2022-06-28       Impact factor: 2.623

2.  Methylenetetrahydrofolate reductase tagging polymorphisms are associated with risk of non-small cell lung cancer in eastern Chinese Han population.

Authors:  Hao Ding; Yafeng Wang; Yuanmei Chen; Chao Liu; Hao Qiu; Mingqiang Kang; Weifeng Tang
Journal:  Oncotarget       Date:  2017-12-04

3.  Association of Promoter Region Polymorphisms of IL-10 Gene with Susceptibility to Lung Cancer: Systematic Review and Meta-Analysis.

Authors:  Jamal Jafari-Nedooshan; Mansour Moghimi; Mohammad Zare; Naeimeh Heiranizadeh; Majid Morovati-Sharifabad; Mohamad Javad Akbarian-Bafghi; Mohammad Hossein Jarahzadeh; Hossein Neamatzadeh
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01

4.  Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma.

Authors:  Vera Jokic; Katarina Savic-Vujovic; Jelena Spasic; Zoran Bukumiric; Mladen Marinkovic; Davorin Radosavljevic; Milena Cavic
Journal:  Dose Response       Date:  2022-08-04       Impact factor: 2.623

5.  Telomerase reverse transcriptase rs2736098 polymorphism is associated with lung cancer: A meta-analysis.

Authors:  Meihua Wang; Yaping Sun
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.